Skip to main content
Professional Technical IVT

oligoprogression

Limited disease progression in few metastatic sites while other disease remains controlled.

Full Definition

Oligoprogression refers to a clinical scenario where cancer progresses in a limited number of metastatic sites (typically 1-5 lesions) while the majority of disease remains stable or controlled by systemic therapy. This pattern of progression suggests that subclones of cancer cells in specific locations have developed resistance to treatment while other sites remain sensitive. Oligoprogression presents an opportunity for local ablative therapies such as stereotactic radiation, radiofrequency ablation, or surgical resection of progressing lesions while continuing effective systemic therapy. This approach may extend the duration of systemic treatment effectiveness and delay the need for treatment changes.

Usage

Usage note: Specify the number and location of progressing sites and the status of other disease sites.

In Context

  • "Imaging demonstrated oligoprogression in two liver lesions while lung metastases remained stable." — Oncology follow-up note
  • "The patient was referred for ablation of oligoprogression sites to continue current systemic therapy." — Treatment planning conference

Also known as

limited progression focal progression

Contrasted with

widespread progression systemic progression

Don't confuse with

oligometastatic disease mixed response

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON